Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb single-arm study of HJ891 in non-small cell lung cancer
CTR20231351Phase 2Active
- Sponsor
- Huajian Future
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HJ891 in non-small cell lung cancer (NSCLC), sponsored by Huajian Future. Started May 2023; status: active.
02
Drugs
HJ891
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20231351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231351.